Clinical practice guidelines, such as those focusing on traumatic stress treatment, can play an important role in promoting inclusion and equity. Based on a review of 14 international trauma treatment guidance documents that explicitly mentioned children, we reflect on two areas in which these guidelines can become more inclusive and equitable; a) representation of children’s cultural background and b) children’s opportunity to have their voice heard. While a few guidelines mentioned that treatment should be tailored to children’s cultural needs, there was little guidance on how this could be done. Moreover, there still appears to be a strong white Western lens across all stages of producing and evaluating the international evidence base. The available documentation also suggested that no young people under the age of 18 had been consulted in the guideline development processes. To contribute to inclusion and equity, we suggest five elements for future national guideline development endeavours. Promoting research and guideline development with, by, and for currently under-represented communities should be a high priority for our field. Our national, regional and global professional associations are in an excellent position to (continue to) stimulate conversation and action in this domain.
No abstract
BACKGROUNDMicroorganism contamination of platelets results in a high risk of transfusion‐related sepsis. Here, the ability of culture vials (BD BACTEC Platelet Aerobic/F and Platelet Anaerobic/F vials, Becton, Dickinson and Company) to detect microorganisms in leukoreduced apheresis platelets (LRAPs) and leukoreduced whole blood platelet concentrates (LRWBPCs) was assessed.METHODSLRAPs or LRWBPCs were inoculated into Aerobic/F and Anaerobic/F vials and placed in a blood culturing system (BD BACTEC FX System, Becton, Dickinson and Company) for growth/monitoring over 7 days to detect preexisting contamination during false‐positive testing. Subsequently, platelets were seeded with microorganisms at approximately 10 CFU/mL or approximately 1 CFU/mL to simulate contamination. Aerobic/F and Anaerobic/F vials were inoculated with platelets (sets of 12). Microorganism growth was detected in the BACTEC FX instrument over 7 days. Overall, 2925 vials were tested.RESULTSOf the 1905 vials included in the microorganism detection phase, 63 (3.3%) Aerobic/F and 16 (0.8%) Anaerobic/F vials were both BACTEC FX and subculture negative. From the remaining 1827 vials, two (0.1%) Anaerobic/F vials were false positive; no false positives were observed in Aerobic/F vials, and no false negatives occurred in either vial type. Of the remaining 1825 vials (99.9%), 955 Aerobic/F and 870 Anaerobic/F vials were true positives. The mean‐time‐to‐detection range was 8.5 to 77 hours. All true‐positive Aerobic/F and Anaerobic/F vials showed 100% agreement with subculture for positive identification of seeded microorganisms.CONCLUSIONAerobic/F and Anaerobic/F vials facilitate contamination detection in LRAPs and LRWBPCs down to approximately 1 CFU/mL. These results support the use of Aerobic/F and Anaerobic/F vials for quality control testing of platelets before transfusion.
No abstract
Introduction Advances in genetic testing have contributed to improvements in our approach to early detection, prevention, and treatment of breast cancer. All populations, however, have not equally benefited from the scientific advances. Cancer genetic testing can directly impact the health and wellbeing of entire families. Uptake of cancer genetic testing continues to be significantly lower among Black patients with unequal access, fear, and medical mistrust all contributing to this disparity. Objective: To address the racial disparity in genetic testing uptake we are developing a short patient-centered video intervention to inform, educate, and encourage Black women and men to consider genetic testing when recommended by a provider. Methods To begin, we created a 15-minute video using data from a recently completed video-based qualitative interview study that included 47 people who have a known genetic or inherited cancer risk. We reviewed coded transcripts of participants’ study videos, with a prioritization of the perspectives of the Black participants about learning about their cancer risk due to a hereditary predisposition, their decision making around genetic testing, and testing experiences. From this review, we created a montage video of short segments from 9 patients (4 of whom were Black). Next, we conducted qualitative stakeholder interviews with 10 Black patients who had undergone genetic testing for cancer within the last year and 10 oncologists and genetic counselors involved in genetic testing (mix of Black and non-Black providers). All participants were made aware that our goal is to develop a video intervention. Interviews were conducted via zoom, with interviewees being shown the montage in segments, followed by questions about why people choose to test (or not), barriers to and concerns around testing. We also asked for thoughts about what information might be important to improve chances of uptake of genetic testing for Black patients. Participants were also asked about whether patient-centered videos were an appropriate intervention strategy, and if so, the preferred voices and messages to be included. Results Initial analysis of the qualitative interviews shows strong support for an intervention focused on patient-centered videos, indicating possible acceptability and clinical utility of this approach. Relatability and representation were mentioned as key, though there was not agreement as to whether all patients need to be Black in an intervention targeting a Black audience. Patients described appreciating seeing other patients discuss genetic testing as a mechanism to reduce risk by facilitating early detection. Patients also felt that describing possible benefits for children and future generations could be a powerful message, and noted that given the widespread fear of cancer, the authenticity of the patients’ perspectives could provide important reassurance. In contrast, patient discussions of their specific problems with insurance and other barriers to testing were identified as possibly problematic for this approach, without explicit identification of solutions. Both providers and patients identified a need for factual information about inherited cancer risk, and the processes and implications of genetic testing alongside experiential content. Patients may not be best placed to deliver such information as it is usually outside of their expertise. Conclusions This developmental work suggests the potential impact of incorporating the patient voice into interventions to increase uptake of cancer genetic testing. Based on this work, we are planning to interview more patients to develop a video-based intervention that will combine information around inherited risk, testing, finances and implications of testing and patients’ perspectives that will then be evaluated in a randomized clinical trial. Citation Format: Katherine C. Smith, Rachel Grob, Avonne Connor, Amanda S. Matchette, Grace-Ann Fasaye, Betty J. May, Michelle McCollough, Emily Warne, Jessica Roth, Kala Visvanathan. Developing a Patient-Centered Video Intervention to Improve Uptake of Genetic Testing for Cancer Among Black Americans: The Stakeholder’s Perspective [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P6-08-02.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.